Allarity Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -146.8% | -146.8% | -53.7% |
| FY2022 | 14,210.6% | -634.5% | -110.4% |
| FY2023 | 432.6% | 18,595.3% | -100.3% |
| FY2024 | -207.6% | -207.6% | -108.2% |
| FY2025 | -114.3% | -114.3% | -61.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -146.8% | -146.8% | -53.7% |
| FY2022 | 14,210.6% | -634.5% | -110.4% |
| FY2023 | 432.6% | 18,595.3% | -100.3% |
| FY2024 | -207.6% | -207.6% | -108.2% |
| FY2025 | -114.3% | -114.3% | -61.5% |